5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
-7.65%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$348M
AUM Growth
+$348M
(-13%)
Cap. Flow
+$4.85M
Cap. Flow
% of AUM
1.39%
Top 10 Holdings %
Top 10 Hldgs %
74.9%
Holding
26
New
2
Increased
2
Reduced
4
Closed
–
Top Buys
| 1 |
Dianthus Therapeutics
DNTH
|
$20.1M |
| 2 |
Tyra Biosciences
TYRA
|
$5.67M |
| 3 |
GH Research
GHRS
|
$2.54M |
| 4 |
Viridian Therapeutics
VRDN
|
$1.99M |
Top Sells
| 1 |
Crinetics Pharmaceuticals
CRNX
|
$11.9M |
| 2 |
Enliven Therapeutics
ELVN
|
$8.71M |
| 3 |
MoonLake Immunotherapeutics
MLTX
|
$2.52M |
| 4 |
Disc Medicine
IRON
|
$2.35M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cidara Therapeutics
CDTX
$1.59B
| $1.07M | 0.31% |
1,134,511
| – | – |
|